Clinician Updates

Launch of HepaFatSmart™ HepaFatSmart™, formerly known as HepaFat-AI, has been redeveloped with a statistical performance now comparable to HepaFatScan®. There has been significant improvement to error reporting with clearer messaging, and improved error detection to minimise undesired impacts on analysis result and to reduce failure rate due to previously strict input quality control rules. Each […]

Topics Covered:  FerriScan® now on 3T MRI machines; Cardiac T2* on 3T scanners (for clinical trials);  HepaFat-Scan now with PDFF + steatosis;  Upgrade of HepaFat-AI; Shorter acquisition for FerriScan® + FerriSmart®; Cardiac T2*-AI & TIF partnership; and New invention for non-invasive liver fibrosis assessment. FerriScan® now on 3T MRI machines We are pleased to advise